Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001021408-03-006804
Filing Date
2003-04-30
Accepted
2003-04-30 13:12:10
Documents
3
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-K d10ka.htm 10-K/A 220444
3 CERTIFICATIONS PURSUANT TO SARBANES-OXLEY ACT dex991.htm EX-99.1 4656
4 GRAPHIC g52163g75k56.jpg GRAPHIC 73310
  Complete submission text file 0001021408-03-006804.txt   300267
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23265 | Film No.: 03671788
SIC: 2834 Pharmaceutical Preparations